Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy

Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy

ObjectivesTo investigate the effect and its mechanisms of different antiviral agents on the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in patients with chronic hepatitis B (CHB).MethodsA total of 125 patients with CHB receiving nucleos(t)ide analogs (NAs)...

Full description

Bibliographic Details
Main Authors: Wen-Xin Wang, Rui Jia, Jin-Wen Song, Xiaoning Zhang, Shuang-Nan Zhou, Fu-Sheng Wang, Junliang Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Microbiology
Subjects:
SARS-CoV-2
vaccination
hepatitis B virus
interferons
antiviral agents
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.1056884/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2022.1056884/full

Similar Items